| P50 | author | De-Maw Chuang | Q122376016 |
| P2093 | author name string | Vinod Charles | |
| | P. H. Reddy | |
| | Vladimir V. Senatorov | |
| | Dan A. Tagle | |
| P2860 | cites work | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| | Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease | Q28114818 |
| | Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation | Q28246858 |
| | Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the antiapoptotic compounds CGP 3466 and R-(-)-deprenyl | Q28263664 |
| | Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase | Q28293728 |
| | Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease | Q28589793 |
| | Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 |
| | Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain | Q29617982 |
| | New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. | Q30322264 |
| | Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts | Q32034809 |
| | Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease | Q33292417 |
| | Recent advances on the pathogenesis of Huntington's disease | Q33604650 |
| | The selective vulnerability of striatopallidal neurons | Q33939097 |
| | Loss of normal huntingtin function: new developments in Huntington's disease research | Q34142361 |
| | Reactive oxygen species are downstream mediators of p53-dependent apoptosis | Q34403292 |
| | Mouse models of Huntington's disease | Q34502714 |
| | Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease | Q35176635 |
| | Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease | Q35212462 |
| | Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death | Q36605673 |
| | Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons | Q37368739 |
| | Stress and the aging hippocampus | Q38461795 |
| | Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta | Q42521955 |
| | Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. | Q45288480 |
| | Cortical and striatal neurone number in Huntington's disease | Q45288776 |
| | Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. | Q45291767 |
| | A role for GAPDH in apoptosis and neurodegeneration | Q45291886 |
| | Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease | Q45293583 |
| | Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo | Q45294913 |
| | Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum | Q45296389 |
| | Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. | Q45296558 |
| | Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts. | Q45296630 |
| | Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders | Q45296636 |
| | Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin | Q45297223 |
| | A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. | Q45298582 |
| | Normal and mutant huntingtin: partners in crime | Q45301570 |
| | Regional and progressive thinning of the cortical ribbon in Huntington's disease | Q45305508 |
| | DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathological Conditions | Q45307545 |
| | Neuronal death in cultured murine cortical cells is induced by inhibition of GAPDH and triosephosphate isomerase | Q47692379 |
| | Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis | Q48275909 |
| | Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis | Q48544021 |
| | Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture | Q49087408 |
| | Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice | Q56772848 |
| | Endothelial cell hypoxic stress proteins | Q58486025 |
| | Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53 | Q73107353 |
| | Ethidium bromide staining reveals rapid cell dispersion in the rat dentate gyrus following ouabain-induced injury | Q73320594 |
| | Huntington's disease | Q74093232 |
| | Nuclear translocation of GAPDH-GFP fusion protein during apoptosis | Q77733233 |
| | mRNA expression of glycolytic enzymes and glucose transporter proteins in ischemic myocardium with and without reperfusion | Q77927019 |
| | Estimation of nuclear population from microtome sections | Q82126847 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| | Huntington's disease | Q190564 |
| | overexpression | Q61643320 |
| P304 | page(s) | 285-297 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Molecular and Cellular Neuroscience | Q6895985 |
| P1476 | title | Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease | |
| | Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington’s disease | |
| P478 | volume | 22 | |